Location of Repository

Investigation of the mechanisms of uridine 5' triphosphate induced contraction of rat mesenteric artery smooth muscle

By Fouzia Panhwar

Abstract

Uridine 5' triphosphate (UTP) is a pyrimidine nucleotide which is released from a variety of cells including platelets and endothelial cells. The release of UTP can lead to vasoconstriction if there is damage to the endothelial layer and hence its actions on the vasculature are important areas of investigation.\ud The research presented in this thesis describes the measurement of isometric contractile responses of rat mesenteric arteries to UTP and of the electrophysiological measurements of ionic currents of smooth muscle cells isolated from these arteries.\ud UTP induced contractions were recorded using various pharmacological tools to investigate the possible signaling mechanisms leading to the contractile response. Particular attention was given to the identification of the ion channels involved in generating the UTP induced contraction. It was clear that the contraction was dependent on Ca2+ influx and my results indicated that this influx was only partly due to an increased activity of voltage-gated Ca2+ channels and that non-selective cation channels were also important. The involvement of PLC is likely as using U73122, a PLC blocker, significantly reduced the UTP induced response. However, the potential involvement of PKC is less convincing as several PKC isoform peptide inhibitors, linked to the carrier peptide Tat(47-57) to render them membrane permeable, failed to affect the contraction.\ud The ionic basis of the UTP induced contraction was studied by measuring the effect of UTP on various ionic currents measured in enzymatically isolated mesenteric artery smooth muscle cells using the whole-cell patch-clamp technique. UTP was found to inhibit both Kv and KATP currents, though in parallel to the contraction results, the UTP induced inhibition of these currents remained even in the presence of PKC block, suggesting a lack of involvement of PKC. Finally, application of UTP resulted in the activation of a non-selective current. An inhibition of K+ currents and the activation of a non-selective cation current would lead to membrane depolarization, the activation of voltage-gated Ca2+ channels and, dependent on the permeability of the non-selective channels, an additional route for Ca2+ influx and hence contraction

Publisher: University of Leicester
Year: 2011
OAI identifier: oai:lra.le.ac.uk:2381/9912

Suggested articles

Preview

Citations

  1. (1997). [ATP-sensitive potassium channel--sulfonylurea receptor].
  2. 10.1111/j.1755-5922.2010.00227.x [Epub ahead of print].
  3. (1999). A contraction-mediating receptor for UTP, presumably P2Y2, in rat vas deferens.
  4. (1972). A direct method for recording tension changes in the wall of small blood vessels in vitro.
  5. (1993). A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor.
  6. (2005). A potassium channel, the M-channel, as a therapeutic target.
  7. (1996). A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function.
  8. (2006). A TRPC-like non-selective cation current activated by alpha 1-adrenoceptors in rat mesenteric artery smooth muscle cells.
  9. (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus.
  10. (1969). Abnormal electroretinogram from a Drosophila mutant.
  11. (1997). Actions of neurotransmitters and other messengers on Ca 2+ channels and K + channels in smooth muscle cells.
  12. (2005). Activation of endothelinA receptors in frog adrenocortical cells stimulates both calcium mobilization from intracellular stores and calcium influx through L-type calcium channels.
  13. (2009). Activation of native TRPC1/C5/C6 channels by endothelin-1 is mediated by both PIP(3) and PIP(2) in rabbit coronary artery myocytes.
  14. (1999). Activation of three types of voltagechannel blocker LOE 908.
  15. (2007). Activators of the PKA and PKG pathways attenuate RhoA-mediated suppression of the KDR current in cerebral arteries.
  16. (1971). Adenine-, guanine- and uridine-5'-phosphonucleotides in blood platelets and storage organelles of various species.
  17. (1998). Agonist-independent inactivation and agonist-induced desensitization of the G protein-activated K + channel (GIRK) in Xenopus oocytes.
  18. (1994). Agonistinduced redistribution of calponin in contractile vascular smooth muscle cells.
  19. (1997). Alpha 1-adrenoceptor activation of a non-selective cation current in rabbit portal vein by 1,2-diacyl-sn-glycerol.
  20. (2003). An introduction to cardiovascular physiology /
  21. (2001). Analysis of purine- and pyrimidine-induced vascular responses in the isolated rat cerebral arteriole.
  22. (1998). Anchoring proteins for protein kinase C: a means for isozyme selectivity.
  23. (1994). Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries.
  24. (1997). Angiotensin II inhibition of ATP-sensitive K + currents in rat arterial smooth muscle cells through protein kinase C.
  25. (2001). Angiotensin II inhibits and alters kinetics of voltage-gated K(+) channels of rat arterial smooth muscle.
  26. (2006). Angiotensin II inhibits inward rectifier K + channels in rabbit coronary arterial smooth muscle cells through protein kinase Calpha.
  27. (2001). Angiotensin II inhibits rat arterial KATP channels by inhibiting steady-state protein kinase A activity and activating protein kinase Ce.
  28. (2007). Angiotensin II-activated protein kinase C targets caveolae to inhibit aortic ATP-sensitive potassium channels.
  29. (2000). Antiproliferative effect of UTP on human arterial and venous smooth muscle cells.
  30. (2010). Assessment and characterization of purinergic contractions and relaxations in the rat urinary bladder. Basic Clin Pharmacol Toxicol,
  31. (1992). ATP activates P2x-contracting and P2y-relaxing purinoceptors in the smooth muscle of mouse vas deferens.
  32. (2003). ATP and UTP responses of cultured rat aortic smooth muscle cells revisited: dominance of P2Y2 receptors.
  33. (1983). ATP-regulated K+ channels in cardiac muscle.
  34. (1997). ATP-sensitive and inwardly rectifying potassium channels in smooth muscle.
  35. (1998). ATP-sensitive K + channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle.
  36. (2008). ATP/UTP activate cation-permeable channels with TRPC3/7 properties in rat cardiomyocytes.
  37. (2004). Biodistribution of intracellularly acting peptides conjugated reversibly to Tat.
  38. (1989). Ca 2+ , crossbridge phosphorylation, and contraction.
  39. (1998). Ca 2+ channel beta3 subunit enhances voltage-dependent relief of G-protein inhibition induced by muscarinic receptor activation and Gbetagamma.
  40. (2006). Ca 2+ signaling, TRP channels, and endothelial permeability.
  41. (1992). Ca(2+)-activated and voltage-gated K+ currents in smooth muscle cells isolated from human mesenteric arteries.
  42. (1994). Calcitonin gene-related peptide activated ATP-sensitive K + currents in rabbit arterial smooth muscle via protein kinase A.
  43. (1986). Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs.
  44. (1990). Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone.
  45. (1994). Calcium sensitivity of BK-type KCa channels determined by a separable domain.
  46. (2006). Calciumactivated potassium channels and the regulation of vascular tone.
  47. (1993). Calponin: thin filament-linked regulation of smooth muscle contraction.
  48. (1993). Calponincalmodulin interaction: properties and effects on smooth and skeletal muscle actin binding and actomyosin ATPases.
  49. (2001). Cargo delivery kinetics of cell-penetrating peptides.
  50. (2004). Caveolae localize protein kinase A signaling to arterial ATP-sensitive potassium channels.
  51. (2011). Caveolae, caveolin, and cavins: Potential targets for the treatment of cardiac disease.
  52. (2007). Caveolin-1 and caveolin-3 regulate Ca 2+ homeostasis of single smooth muscle cells from rat cerebral resistance arteries.
  53. (2010). Caveolin-1 assembles type 1 inositol 1,4,5-trisphosphate receptors and canonical transient receptor potential 3 channels into a functional signaling complex in arterial smooth muscle cells.
  54. (2001). Cell physiology : source book : a molecular approach / edited by Nicholas Sperelakis.
  55. (1997). Cellular Aspects of Smooth Muscle Function,
  56. channels by angiotensin II in small-diameter coronary artery of isoproterenolinduced hypertrophied model.
  57. (1992). Characteristics of CGRP-induced relaxation in rabbit ophthalmic artery.
  58. (1990). Chelerythrine is a potent and specific inhibitor of protein kinase
  59. (1986). Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin.
  60. (1998). Coexpression of ligand-gated P2X and G protein-coupled P2Y receptors in smooth muscle. Preferential activation of P2Y receptors coupled to phospholipase C (PLC)-beta1 via Galphaq/11 and to PLCbeta3 via Gbetagammai3.
  61. (1998). Comparison of the actions of ATP and UTP and P(2X1) receptors in smooth muscle of the rat tail artery.
  62. (1996). Comprehensive human physiology : from cellular mechanisms to integration
  63. (2005). Constitutively active L-type Ca 2+ channels.
  64. (2004). Continuous elevation of intracellular Ca 2+ is essential for the development of cerebral vasospasm.
  65. (2005). Contractile properties of the cultured vascular smooth muscle cells: the crucial role played by RhoA in the regulation of contractility.
  66. (1989). Crossbridge phosphorylation and the energetics of contraction in the swine carotid media.
  67. (2000). Differential regulation of Ca(2+) sparks and Ca(2+) waves by UTP in rat cerebral artery smooth muscle cells.
  68. (2004). Direct association and translocation of PKC-alpha with calponin.
  69. (2008). Direct association of calponin with specific domains of PKC-alpha.
  70. (1978). Direct evidence for ATP release from non-adrenergic, non-cholinergic ("purinergic") nerves in the guinea-pig taenia coli and bladder.
  71. (2006). Direct G protein modulation of Cav2 calcium channels.
  72. (1996). Dual regulation of cerebrovascular tone by UTP: P2U receptor-mediated contraction and endothelium-dependent relaxation.
  73. (2011). Dual signaling pathways of arterial constriction by extracellular uridine 5'-triphosphate in the rat.
  74. (1993). Effect of norepinephrine on rat basilar artery in vivo.
  75. (1995). Effects of potassium channel activators on isolated cerebral arteries of large and small diameter in the cat.
  76. (1991). Effects of purines and pyrimidines on the rat mesenteric arterial bed.
  77. (2007). Electrophysiological and pharmacological characterization of the K(ATP) channel involved in the K + -current responses to FSH and adenosine in the follicular cells of Xenopus oocyte.
  78. (2000). Electrophysiological effects of endothelin-1 and their relationship to contraction in rat renal arterial smooth muscle.
  79. (2007). Endothelin-1 activates a Ca 2+ -permeable cation channel with TRPC3 and TRPC7 properties in rabbit coronary artery myocytes.
  80. (2005). Endothelin-1 inhibits inward rectifier K + channels in rabbit coronary arterial smooth muscle cells through protein kinase C.
  81. (2009). Endothelin-I and angiotensin II inhibit arterial voltage-gated K + channels through different protein kinase C isoenzymes.
  82. (1998). Endothelin: receptor subtypes, signal transduction, regulation of Ca 2+ transients and contractility in rabbit ventricular myocardium.
  83. (1997). Endothelium-derived hyperpolarizing factor(s): updating the unknown.
  84. (2011). ET-1 induced Elevation of intracellular calcium in clonal neuronal and embryonic kidney cells involves endogenous endothelin-A receptors linked to phospholipase C through Galpha(q/11). Pharmacol Res,
  85. (1997). Evidence for a novel P2X purinoceptor in human placental chorionic surface arteries.
  86. Evidence for three distinct ADP receptors on human platelets.
  87. (1986). Evidence for two distinct calcium channels in rat vascular smooth muscle cells in short-term primary culture.
  88. (1998). Evidence that P2Y4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP.
  89. (2001). Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle.
  90. (1997). Extracellular nucleotide-induced [Ca 2+ ]i elevation in rat basilar smooth muscle cells.
  91. (1998). Functions of large conductance Ca 2+ -activated (BKCa), delayed rectifier (KV) and background K + channels in the control of membrane potential in rabbit renal arcuate artery.
  92. (2007). G protein activation inhibits gating charge movement in rat sympathetic neurons.
  93. (2008). G protein betagamma subunits modulate the number and nature of exocytotic fusion events in adrenal chromaffin cells independent of calcium entry.
  94. (2010). G protein-coupled receptor kinase 2 and arrestin2 regulate arterial smooth muscle P2Y-purinoceptor signalling.
  95. (2006). Glucose reduces endothelin inhibition of voltage-gated potassium channels in rat arterial smooth muscle cells.
  96. (2005). Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter.
  97. (1989). Hyperpolarizing vasodilators activate ATP-sensitive K + channels in arterial smooth muscle.
  98. (2007). Hyposmotic challenge inhibits inward rectifying K + channels in cerebral arterial smooth muscle cells.
  99. (1992). i, membrane potential and force in isolated rat small arteries.
  100. (2000). Identification of calponin as a novel substrate of Rhokinase.
  101. (1991). Identification of intracellular receptor proteins for activated protein kinase C.
  102. (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
  103. (1993). Increased influence of calcium and nicardipine on rabbit basilar artery reactivity after brief subarachnoid hemorrhage.
  104. (2007). Increased inhibition of inward rectifier K +
  105. (1993). Inhibition of protein kinase C by Nmyristoylated peptide substrate analogs.
  106. (2009). Inhibition of TRPC1/TRPC3 by PKG contributes to NO-mediated vasorelaxation.
  107. (1998). Inhibition of voltagegated K + current in rat intrapulmonary arterial myocytes by endothelin-1.
  108. (2009). Inositol trisphosphate and calcium signalling mechanisms.
  109. (1996). Interaction between the L-type Ca 2+ channel and the Ca(2+)-activated K+ channel in the fluctuating myogenic contraction in the rabbit basilar artery.
  110. (1986). Intracellular calcium and smooth muscle contraction.
  111. (1992). Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase
  112. (2001). Involvement of prostanoid release in the mediation of UTP-induced cerebrovascular contraction in the rat.
  113. (2005). Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress.
  114. (2010). Inwardly rectifying potassium channels: their structure, function, and physiological roles.
  115. (1996). Ion channels : molecules in action /
  116. (1998). K + channel modulation in arterial smooth muscle.
  117. (1993). K channel activation by nucleotide diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells.
  118. (1994). KATP channels in vascular smooth muscle.
  119. (2008). KIR channels function as electrical amplifiers in rat vascular smooth muscle.
  120. (2004). KR-31378, a novel benzopyran analog, attenuates hypoxia-induced cell death via mitochondrial KATP channel and protein kinase C-epsilon in heart-derived H9c2 cells.
  121. (2002). Localization of peripheral dopamine D1 and D2 receptors in rat corpus cavernosum.
  122. (1995). Localization of protein kinases by anchoring proteins: a theme in signal transduction.
  123. (2008). Luminal ATP-induced contraction of rabbit pulmonary arteries and role of purinoceptors in the regulation of pulmonary arterial pressure.
  124. (2005). Maxi-K channels localize to caveolae in human myometrium: a role for an actinchannel-caveolin complex in the regulation of myometrial smooth muscle K + current.
  125. (2004). MaxiK channel roles in blood vessel relaxations induced by endothelium-derived relaxing factors and their molecular mechanisms.
  126. (1985). Measurements of the membrane potential of arterial smooth muscle in anesthetized animals and its relationship to changes in artery diameter.
  127. (2009). Mechanism of asynchronous Ca(2+) waves underlying agonist-induced contraction in the rat basilar artery.
  128. (2000). Mechanisms involved in UTP-induced contraction in isolated rat aorta.
  129. (2001). Mechanisms of coronary artery depolarization by uridine triphosphate.
  130. (1996). Mechanisms of smooth muscle contraction.
  131. (1987). Mg myogenic tone and agonist-induced responsiveness of blood vessels.
  132. (2008). Modification of K + channel-drug interactions by ancillary subunits.
  133. (1998). Molecular basis for ADP-induced platelet activation.
  134. (2005). Molecular determinants of voltage-gated potassium currents in vascular smooth muscle.
  135. (2003). Molecular physiology of low-voltage-activated t-type calcium channels.
  136. (2002). Molecular physiology of P2X receptors.
  137. (2005). Multiple P2Y receptors couple to calcium-dependent, chloride channels in smooth muscle cells of the rat pulmonary artery.
  138. (2001). Myosin light chain kinase- and PKC-dependent contraction of LES and esophageal smooth muscle.
  139. (1985). Myosin phosphorylation, force, and maximal shortening velocity in neurally stimulated tracheal smooth muscle.
  140. (1976). Noise analysis of drug induced voltage clamp currents in denervated frog muscle fibres.
  141. (1998). Nonselective effects of the putative phospholipase C inhibitor, U73122, on adenosine A1 receptor-mediated signal transduction events in Chinese hamster ovary cells.
  142. (1902). On the local reactions of the arterial wall to changes of internal pressure.
  143. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC.
  144. (1999). P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia-reperfusion.
  145. (2008). P2 receptors in cardiovascular regulation and disease.
  146. (1996). P2-purinoceptor-mediated formation of inositol phosphates and intracellular Ca 2+ transients in human coronary artery smooth muscle cells.
  147. (2010). P2X and P2Y Receptors Mediate Contraction Induced by Electrical Field Stimulation in Feline Esophageal Smooth Muscle.
  148. (2004). P2X receptor-stimulated calcium responses in preglomerular vascular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid.
  149. (2002). P2Y(1) and P2Y(2) receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed.
  150. (2002). Patch-clamp analysis : advanced techniques / edited by
  151. (2010). Pathophysiology of voltage-gated K+ channels in vascular smooth muscle cells: Modulation by protein kinases.
  152. (2002). Pharmacological characterization of a UTPsensitive P2Y nucleotide receptor in organ cultured coronary arteries.
  153. (1995). Pharmacological selectivity of the cloned human P2Upurinoceptor: potent activation by diadenosine tetraphosphate.
  154. (1994). Pharmacology and structure of high conductance calcium-activated potassium channels.
  155. (1995). Pharmacology of ATP-sensitive K + currents in smooth muscle cells from rabbit mesenteric artery.
  156. (2004). Pharmacology of cardiac potassium channels.
  157. (1988). Phorbol ester increases the dihydropyridine-sensitive calcium conductance in a vascular smooth muscle cell line.
  158. (2008). Phospholipase C-delta1 modulates sustained contraction of rat mesenteric small arteries in response to noradrenaline, but not endothelin-1.
  159. (2008). Phospholipase C{delta}1 modulates sustained contraction of rat mesenteric small arteries in response to noradrenaline, but not endothelin-1. Am J Physiol Heart Circ Physiol.
  160. (1994). Phosphorylation of calponin by PKC is blocked by F-actin in vitro.
  161. (1995). Physiological roles and properties of potassium channels in arterial smooth muscle.
  162. (2008). Physiological roles of K + channels in vascular smooth muscle cells.
  163. (2007). PKC delta-isoform translocation and enhancement of tonic contractions of gastrointestinal smooth muscle.
  164. (2003). PKC isozyme selective regulation of cloned human cardiac delayed slow rectifier K current.
  165. (2005). PKCdelta mediates testosterone-induced increases in coronary smooth muscle Cav1.2.
  166. (2006). PKD at the crossroads of DAG and PKC signaling.
  167. (1994). Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification.
  168. (1997). Potential signalling roles for UTP and UDP: sources, regulation and release of uracil nucleotides.
  169. (1984). Pressure-dependent membrane depolarization in cat middle cerebral artery.
  170. (2003). Properties of a constitutively active Ca 2+ -permeable non-selective cation channel in rabbit ear artery myocytes.
  171. (2000). Properties of P2X and P2Y receptors are dependent on artery diameter in the rat mesenteric bed.
  172. (1987). Protein kinase C contains a pseudosubstrate prototope in its regulatory domain.
  173. (2005). Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension.
  174. (1994). Protein kinase-C mediates dual modulation of L-type Ca 2+ channels in human vascular smooth muscle.
  175. (2006). protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.
  176. (2007). Purine and pyrimidine receptors.
  177. (1976). Purine nucleotides.
  178. (1994). Purinoceptors: Are there families of P2X and P2Y purinoceptors?
  179. (2004). Pyrimidine nucleotides suppress KDR currents and depolarize rat cerebral arteries by activating Rho kinase.
  180. (1999). Quantitation of extracellular UTP using a sensitive enzymatic assay.
  181. (2007). Rang and Dale's Pharmacology,
  182. (1990). Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase Cdependent processes on cell responsiveness.
  183. (1998). Receptors for purines and pyrimidines.
  184. (1996). Regulation of 4-aminopyridine-sensitive, delayed rectifier K + channels in vascular smooth muscle by phosphorylation.
  185. (1996). Regulation of myosin phosphatase by Rho and Rhoassociated kinase (Rho-kinase).
  186. (2004). Regulation of myosin phosphorylation and myofilament Ca 2+ sensitivity in vascular smooth muscle.
  187. (1998). Regulation of smooth muscle actin-myosin interaction and force by calponin.
  188. (2010). Regulation of vascular smooth muscle function. IN
  189. (2000). Rho GTPases and their effector proteins.
  190. (1993). Role of extracellular calcium and calcium channels in the response of human placental venous smooth muscle to endothelin-1.
  191. (2009). Role of protein kinase Czeta and calcium entry in KCl-induced vascular smooth muscle calcium sensitization and feedback control of cellular calcium levels.
  192. (2005). Role of the PKC/CPI-17 pathway in enhanced contractile responses of mesenteric arteries from diabetic rats to alpha-adrenoceptor stimulation.
  193. (2000). Signal transduction by G-proteins, rhokinase and protein phosphatase to smooth muscle and non-muscle myosin II.
  194. (1998). Signal transduction by protein kinase C in mammalian cells.
  195. (1994). Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action.
  196. (2010). Silencing vascular smooth muscle ATP-sensitive K + channels with caveolin-1.
  197. (1986). Single apamin-blocked Ca-activated K + channels of small conductance in cultured rat skeletal muscle.
  198. (1976). Single-channel currents recorded from membrane of denervated frog muscle fibres.
  199. (1997). Small-conductance Ca(2+)-dependent K + channels activated by ATP in murine colonic smooth muscle.
  200. (1996). Spontaneous transient outward currents in smooth muscle cells.
  201. (1992). Structural elements involved in specific K+ channel functions.
  202. (1995). Structure and function of voltage-gated ion channels.
  203. (1988). Sustained contraction of vascular smooth muscle: calcium influx or C-kinase activation?
  204. (2005). Tat peptide-mediated cellular delivery: back to basics.
  205. (1994). Tat-mediated delivery of heterologous proteins into cells.
  206. (1992). The ATP-sensitive K + channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog.
  207. (1970). The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices.
  208. (2007). The effects of protein kinase C (PKC) on the tension of normal and passively sensitized human airway smooth muscle and the activity of voltage-dependent delayed rectifier potassium channel (Kv).
  209. (1985). The function of myosin and myosin light chain kinase phosphorylation in smooth muscle.
  210. (1994). The intrinsic gating of inward .
  211. (1997). The P2U purinoceptor obligatorily engages the heterotrimeric G protein G16 to mobilize intracellular Ca
  212. (2005). The P2Y2 nucleotide receptor interacts with alphav integrins to activate Go and induce cell migration.
  213. (1997). The past, present and future of purine nucleotides as signalling molecules.
  214. (1929). The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart.
  215. (1996). The properties and distribution of inward rectifier potassium currents in pig coronary arterial smooth muscle.
  216. (2005). The protein kinase C inhibitor, bisindolylmaleimide (I), inhibits voltage-dependent K + channels in coronary arterial smooth muscle cells.
  217. (1998). The regulation of vascular function by P2 receptors: multiple sites and multiple receptors.
  218. (2001). The TRP ion channel family.
  219. (2007). Transient receptor potential cation channels in disease.
  220. (2010). TREK-1 K(+) Channels in the Cardiovascular System: Their Significance and Potential as a Therapeutic Target.
  221. (2002). TRP channel proteins and signal transduction.
  222. (2007). TRPC channels: integrators of multiple cellular signals. Handb Exp Pharmacol,
  223. (2005). TRPC3 mediates pyrimidine receptor-induced depolarization of cerebral arteries.
  224. (1987). Two types of calcium channels in single smooth muscle cells from rabbit ear artery studied with whole-cell and single-channel recordings.
  225. (2010). Type 1 inositol 1,4,5-trisphosphate receptors mediate UTP-induced cation currents, Ca 2+ signals, and vasoconstriction in cerebral arteries.
  226. (2006). Upregulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
  227. (2005). Uridine triphosphate (UTP) is released during cardiac ischemia.
  228. (2001). UTP as an extracellular signaling molecule.
  229. (2008). Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance.
  230. (2008). Visualizing the temporal effects of vasoconstrictors on PKC translocation and Ca 2+ signaling in single resistance arterial smooth muscle cells.
  231. (2003). Voltage gated Ca channels. The L-type Ca Chapter 2 Material and Methods Chapter 6 References
  232. (1994). Voltage window for sustained elevation of cytosolic calcium in smooth muscle cells.
  233. (2008). Voltagedependent C-type inactivation in a constitutively open K+ channel.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.